Clinical studies recruiting near Duarte

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · City of Hope ( Site 0014) · Merck Sharp & Dohme LLC · NCT04165070 A Registry for People With T-cell Lymphoma
Phase N/A · City of Hope Cancer Center (Data collection only) · Memorial Sloan Kettering Cancer Center · NCT05978141 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · City of Hope Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT06172296 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · City of Hope · Vertex Pharmaceuticals Incorporated · NCT04786262 Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
Phase N/A · City of Hope Medical Center · City of Hope Medical Center · NCT07224724 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0137 · Bristol-Myers Squibb · NCT07291076 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · City of Hope Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05691478 A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Phase 1 · City of Hope · Dispatch Biotherapeutics · NCT07544589 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in
Phase 1 · City of Hope Duarte · Cartography Biosciences · NCT07321106 A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · City of Hope National Medical Center · Pfizer · NCT07090499 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Phase 1 · Research Site · AstraZeneca · NCT06218914 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Le
Phase 1 · City of Hope Medical Center · City of Hope Medical Center · NCT05263284 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · City of Hope (City of Hope National Medical Center, City of · Pfizer · NCT07421700 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · City of Hope Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT04172532 Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hemato
Phase N/A · City of Hope Medical Center · City of Hope Medical Center · NCT07235501 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · City of Hope /ID# 261468 · AbbVie · NCT06109272 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · City of Hope Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT06860594 Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Can
Phase 2 · City of Hope Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05691465 PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · City of Hope National Medical Center · Pulmotect, Inc. · NCT06665100 A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Phase 1 · City of Hope · Crossbow Therapeutics, Inc. · NCT06994676 A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With
Phase 2 · City of Hope--Duarte · Biostar Pharma, Inc. · NCT06764940 A Study of KK2269 in Adult Participants With Solid Tumors
Phase 1 · City Of Hope National Medical Center · Kyowa Kirin Co., Ltd. · NCT06266299 Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Prima
Phase 2 · City of Hope Medical Center · City of Hope Medical Center · NCT04871607 A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/Phase 2 · Site-113 · Biohaven Therapeutics Ltd. · NCT06384807 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 2129 · Turning Point Therapeutics, Inc. · NCT03093116 Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · City of Hope Comprehensive Cancer Center · National Cancer Institute (NCI) · NCT05372614 First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Phase 1 · Research Site · Plexium, Inc. · NCT07284186 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · City of Hope · Regeneron Pharmaceuticals · NCT05685173 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · City of Hope Comprehensive Cancer Center · Hoffmann-La Roche · NCT04929223

Look up another city

Look up another condition